As part of an effort by the FDA and the Federal Trade Commission to halt deceptive online advertisements and sales of products misrepresented as diabetes cures or treatments, the agencies have sent approximately 180 letters and advisories to Internet outlets in the United States, Mexico, and Canada.
The joint initiative, conducted in cooperation with Mexican and Canadian agencies, has also resulted in FDA warning letters to 24 manufacturers and distributors of dietary supplement products. Failure to promptly correct the violations may result in seizure of the products or legal action against the firms.
Continue Reading
